Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Sethi Ouandji"'
Autor:
Marion Ciudad, Sethi Ouandji, Baptiste Lamarthée, Claudie Cladière, Thibault Ghesquière, Martin Nivet, Marine Thébault, Romain Boidot, Agnès Soudry-Faure, Sandy Chevrier, Corentin Richard, Thibault Maillet, François Maurier, Hélène Greigert, Coraline Genet, André Ramon, Malika Trad, Valérie Predan, Philippe Saas, Maxime Samson, Bernard Bonnotte, Sylvain Audia
Publikováno v:
Haematologica, Vol 109, Iss 2 (2023)
Warm autoimmune hemolytic anemia (wAIHA) is a rare acquired autoimmune disease mediated by antibodies targeting red blood cells. The involvement of CD4 T-helper cells has been scarcely explored, with most findings extrapolated from animal models. Her
Externí odkaz:
https://doaj.org/article/91111fd73e6244f8b2a6f13f971b6c7a
Autor:
Sylvain Audia, Matthieu Mahévas, Martin Nivet, Sethi Ouandji, Marion Ciudad, Bernard Bonnotte
Publikováno v:
HemaSphere, Vol 5, Iss 6, p e574 (2021)
Immune thrombocytopenia (ITP) is a rare autoimmune disease due to both a peripheral destruction of platelets and an inappropriate bone marrow production. Although the primary triggering factors of ITP remain unknown, a loss of immune tolerance—most
Externí odkaz:
https://doaj.org/article/3163cb41195d446b912420c25f2b41cc
Autor:
Maxime Samson, Hélène Greigert, Marion Ciudad, Claire Gerard, Thibault Ghesquière, Malika Trad, Marc Corbera‐Bellalta, Coraline Genet, Sethi Ouandji, Claudie Cladière, Marine Thebault, Kim Heang Ly, Eric Liozon, François Maurier, Boris Bienvenu, Benjamin Terrier, Loïc Guillevin, Pierre Charles, Valérie Quipourt, Hervé Devilliers, Pierre‐Henry Gabrielle, Catherine Creuzot‐Garcher, Georges Tarris, Laurent Martin, Philippe Saas, Sylvain Audia, Maria Cinta Cid, Bernard Bonnotte
Publikováno v:
Clinical & Translational Immunology, Vol 10, Iss 9, Pp n/a-n/a (2021)
Abstract Objectives To study the percentage, suppressive function and plasticity of Treg in giant cell arteritis (GCA), and the effects of glucocorticoids and tocilizumab. Methods Blood samples were obtained from 40 controls and 43 GCA patients at ba
Externí odkaz:
https://doaj.org/article/93e68fc4511c4672a319ffc0784fe177
Autor:
Philippe Saas, Boris Bienvenu, Sylvain Audia, Georges Tarris, François Maurier, T. Ghesquiere, Malika Trad, Benjamin Terrier, Claire Gerard, Marc Corbera-Bellalta, Marion Ciudad, Bernard Bonnotte, Hervé Devilliers, Pierre Charles, Coraline Genet, Maria C. Cid, Marine Thébault, Loïc Guillevin, Pierre-Henry Gabrielle, Maxime Samson, Eric Liozon, Kim Heang Ly, Hélène Greigert, Catherine Creuzot-Garcher, Valérie Quipourt, Claudie Cladière, Sethi Ouandji, Laurent Martin
Publikováno v:
Clinical & Translational Immunology
Clinical & Translational Immunology, Wiley, 2021, 10 (9), pp.e1332. ⟨10.1002/cti2.1332⟩
Clinical & Translational Immunology, Vol 10, Iss 9, Pp n/a-n/a (2021)
Clinical & Translational Immunology, Wiley, 2021, 10 (9), pp.e1332. ⟨10.1002/cti2.1332⟩
Clinical & Translational Immunology, Vol 10, Iss 9, Pp n/a-n/a (2021)
Objectives To study the percentage, suppressive function and plasticity of Treg in giant cell arteritis (GCA), and the effects of glucocorticoids and tocilizumab. Methods Blood samples were obtained from 40 controls and 43 GCA patients at baseline an
Autor:
Andrea Brazdova, Bernard Bonnotte, Philippe Saas, T. Ghesquiere, Maxime Samson, Marine Thébault, Sylvain Audia, Claire Gerard, Claudie Cladière, Hélène Greigert, Nona Janikashvili, Sethi Ouandji, Marion Ciudad, Clovis Boibessot
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Oncoimmunology
article-version (VoR) Version of Record
Oncoimmunology
article-version (VoR) Version of Record
Background Immunosuppressive cell-based therapy is a recent strategy for controlling Graft-versus-Host Disease (GvHD). Such cells ought to maintain their suppressive function in inflammatory conditions and in the presence of immunosuppressive agents
Autor:
Arthur Imbach, H. Greigert, Christelle Mausservey, Nadine Magy-Bertrand, Laurent Voillat, Bernard Bonnotte, Guillaume Mourey, Sethi Ouandji, Sylvain Audia, Eric Deconinck, Maxime Samson, Thibault Ghesquière, Denis Caillot, Nicolas Falvo, Jean-Baptiste Picque, Thomas Rogier
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 1998, p 1998 (2020)
Journal of Clinical Medicine
Volume 9
Issue 6
Journal of Clinical Medicine
Volume 9
Issue 6
Immune thrombocytopenia (ITP) is a rare autoimmune disease due to autoantibodies targeting platelet glycoproteins (GP). The mechanism of platelet destruction could differ depending on the specificity of antiplatelet antibodies: anti-GPIIb/IIIa antibo
Autor:
T. Ghesquiere, Philippe Saas, Sylvain Audia, François Maurier, T. Maillet, Sethi Ouandji, Marion Ciudad, Claudie Cladière, Bernard Bonnotte, Maxime Samson
Publikováno v:
La Revue de Médecine Interne. 41:A44-A45
Introduction L’anemie hemolytique auto-immune est une maladie auto-immune (MAI) rare et acquise, dont le mecanisme physiopathologique principal est la production d’auto-anticorps (auto-Ac) par des lymphocytes B (LB) auto-reactifs reconnaissant de
Autor:
Bernard Bonnotte, Martin Nivet, Matthieu Mahévas, Sethi Ouandji, Marion Ciudad, Sylvain Audia
Publikováno v:
HemaSphere
HemaSphere, Vol 5, Iss 6, p e574 (2021)
HemaSphere, Vol 5, Iss 6, p e574 (2021)
Immune thrombocytopenia (ITP) is a rare autoimmune disease due to both a peripheral destruction of platelets and an inappropriate bone marrow production. Although the primary triggering factors of ITP remain unknown, a loss of immune tolerance—most
Autor:
Sabine Berthier, Marion Ciudad, Claudie Cladière, Sethi Ouandji, Sylvain Audia, Vanessa Leguy-Seguin, Bernard Bonnotte, Maxime Samson, T. Ghesquiere
Publikováno v:
La Revue de Médecine Interne. 41:A65
Autor:
Claire Gérard, Marine Thébault, Baptiste Lamarthée, Coraline Genet, Florine Cattin, Andréa Brazdova, Nona Janikashvili, Claudie Cladière, Marion Ciudad, Séthi Ouandji, Thibault Ghesquière, Hélène Greigert, Claire Tinel, Olivier Adotevi, Philippe Saas, Maxime Samson, Sylvain Audia, Bernard Bonnotte
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Recently developed cell-based therapies have shown potential for graft-versus-host disease (GvHD) mitigation. Our team previously developed a protocol to generate human monocyte-derived suppressor Cells (HuMoSC), a subpopulation of CD33+ suppressor c
Externí odkaz:
https://doaj.org/article/d0bce2cc24f54a32bbc91216ac963b01